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Mechanism of glycine protection in hypoxic injury: Analogies with
glycine receptor. Addition of glycine to the recirculating perfusate of
isolated perfused rat kidneys protects against hypoxic injury to the
medullary thick ascending limb and slows functional deterioration in the
course of perfusion. This effect is dependent on dose; the earliest
significant protection is seen at 0.25 mrvi, and the protective effects
increase as glycine concentration is increased to 2 ms, the highest level
tested. Two specific agonists of the strychnine-insensitive (NMDA)
glycine receptor in neural membranes, 1-aminocyclopropane carboxylic
acid (ACC) and d-serine, also exerted a cytoprotective effect at a
concentration of 2 mM. On the other hand, 1-serine and taurine,
ineffective agonists of the NMDA-glycine receptor but effective ago-
fists of the strychnine-sensitive glycine receptor, had no protective
effect in this system. Two antagonists to glycine at its binding site on the
N-methyl-D-aspartate (NMDA) receptor, 7-chlorokynurenic acid (2
mM) and indole-2-carboxylic acid (12.5 mM), did not reverse the
cytoprotective action of 0.25 msi glycine. The data are consistent with
a ligand-acceptor type of interaction to account for cytoprotection. The
configuration of the glycine acceptor may resemble, but is not identical
with, that of certain glycine receptors in the nervous system.
Glycine appears to blunt or prevent cellular injury in a
number of experimental models. In dispersed proximal tubules
of rabbit kidneys, glycine reduces damage caused by hypoxia
[1—4], metabolic inhibitors [5] or ouabain [6]. Similar protection
against injury caused by cold ischemia or metabolic inhibitors
has been observed in cultured hepatocytes [7, 8]. In isolated
perfused rat kidneys, addition of 2 to 5 m of glycine to the
recirculating perfusate greatly diminishes functional deteriora-
tion, biochemical signs of proximal tubular injury [9], and
morphological evidence of hypoxic damage to the medullary
thick ascending limb [10]. The cytoprotective property of
glycine does not seem to be related to its metabolism [9, 11, 12],
to the maintenance of cellular levels of ATP or calcium [13, 14],
or to the ability of glycine to conjugate with fatty acids via
glycine-N-acyl transferase [11].
Similar though less marked protection is provided in dis-
persed proximal tubules of the kidney by other small amino
acids, including d-alanine, 1-alanine, beta-alanine, and the syn-
thetic glycine analogue, 1-amino-cyclopropane carboxylic acid
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(ACC) [3], suggesting a structural requirement for cytoprotec-
tion. Glycine receptors are present in the central nervous
system, where two types have been identified. One, a strych-
nine-sensitive glycine receptor, controls the gating of chloride
channels and inhibits neural excitation. Partial agonists for this
receptor include 1-alanine, d-alanine, beta-alanine, taurine and
1-serine [15]. A second receptor site with high binding affinity
for glycine modulates activity of the N-methyl, d-aspartate
(NMDA) excitatory receptor [16]. Unlike the first type, it
preferentially binds d-serine and ACC, and is insensitive to
strychnine.
In the present experiments in isolated perfused rat kidneys,
we investigated the relationship of the dose of glycine to the
cytoprotection seen in this system and examined the protective
effect of various agonists and antagonists of neural glycine
receptors.
Methods
Male Sprague-Dawley rats weighing 300 to 320 g and allowed
free access to water were used for all experiments. Isolated
perfusion of the right kidney was performed according to the
method of Ross, Epstein and Leaf [17]. The perfusion medium
consisted of a Krebs-Ringer-Henseleit solution containing (in
mM): Na 143; K 4.5; bicarbonate 24; Ca 2.5; Mg 1.2; phosphate
1.2; pH 7,4 when gassed with 5% C02, 95% 02; and bovine
serum albumin at a concentration of 6.7 g/dl. All perfusions
were carried out for 90 minutes. Urine collections and pet-fusate
samples were obtained for clearance measurements every 10
minutes after 30 minutes of stabilization.
Kidneys were perfused at a constant pressure of 100 mm Hg
at the catheter tip. The rate of perfu sate flow was monitored by
a Brooks flowmeter in line. Glomerular filtration rate was
estimated from the clearance of 3H inulin (New England Nu-
clear, Boston, Massachusetts, USA). Fractional sodium reab-
sorption was calculated from the concentration of Na in the
perfusate and urine, and the inulin clearance. Lactic dehydro-
genase (LDH) and glucose concentrations were determined in
samples of urine and perfusate by automated enzymatic analy-
sis. LDH release was expressed as the amount of enzyme
appearing in urine and perfusate during the last hour of perfu-
sion.
Morphological techniques
The morphology of the kidneys in each group was examined.
A three-way stopcock was incorporated into the circuit 5 cm
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Table 1. Functional data in kidneys perfused with various concentrations of glycine
from the arterial cannula to allow perfusion with the fixation
solution at the same pressure applied during the functional
studies for an additional five to eight minutes. The fixative
solution contained 1.25% glutaraldehyde in 0.1 M phosphate
buffer (pH 7.4). The sections were postfixed in buffered 2%
0s04, dehydrated and embedded in araldite-epon 812 mixture.
Large 3 x 3 1 micron sections of the outer medulla were cut,
stained with methylene blue and examined by light microscopy.
The histological evaluation was completed by Dr. S. Rosen in
a "blinded" fashion; that is, without knowledge of the experi-
mental condition. Three zones of the inner stripe were ana-
lyzed: Upper third (A level): All mTALs intersecting a line
immediately adjacent (within 0.2 mm of) the outer stripe;
middle third (B level): All mTALs intersecting a line drawn
midway between the borders of the inner stripe; and a lower
third (C level): All mTALs intersecting a line immediately
adjacent to (within 0.2 mm of) the inner medulla. These points
were chosen for analysis because they provided areas in which
topographical landmarks were easily ascertained. A percentage
score was used to indicate the fraction of tubules involved with
moderate changes (blatant mitochondrial swelling with exten-
sive nuclear pyknosis), or severe changes (blatant mitochon-
drial swelling, extensive nuclear pyknosis and cell fragmenta-
tion). Between 80 and 270 tubules (mean 130) were evaluated
per kidney.
Experimental design
Dose-response relation of glycine cytoprotection. The pro-
tective action of glycine in the isolated perfused rat kidney was
evaluated at concentrations of 0, 0.1, 0.25, 0.5, 1 and 2 mtvi
glycine added to the recirculating perfusate (4 to 16 experiments
per group).
Glycine receptor agonists and antagonists. The effects of
glycine receptor agonists were compared to those of glycine.
The agents used were glycine, 1-aminocyclopropane carboxylic
acid (ACC), d-serine, 1-serine and taurine (5 to 7 experiments
per group). Each was added to the perfusate at a concentration
of 2 m. Two antagonists to glycine at its binding site on the
NMDA receptor were tested: 7-chlorokynurenic acid, 2 mti (N
= 8), and indole-2-carboxylic acid, 12.5 mrt (N = 6). In order to
achieve the highest possible concentration of antagonists rela-
tive to that of glycine, these were tested in the presence of 0.25
mM glycine.
Statistics
Results are presented as mean SEM. One and two-way
analysis of variance with the Neuman-Keuls test were used for
comparisons between the different groups and between re-
peated measurements within groups. Simple correlations were
performed as detailed below.
Results
Dose-dependent effects of glycine (Table I, Fig. 1)
The structural and functional protection afforded by glycine
was proportional to dose as glycine concentration was varied
from 0.1 m to 2 m. Cytoprotection in the mTAL was most
marked at the deepest (C) level of the inner stripe. Significant
reduction in severe morphological injury was apparent at 0.25
mM and was pronounced at 2 mt'vi. The inverse correlation
between glycine concentration and severe injury to zone C was
highly significant (r = —0.74; P < 0.0001).
Glycine concentration was directly correlated with glomeru-
lar filtration rate at 60 and 90 minutes of perfusion (Table 1, Fig.
2, r = 0.65, P < 0.0001). The release of lactic dehydrogenase
(Table I) was correlated with severe mTAL injury in zone C (r
= 0.74, P < 0.0001) and inversely correlated with glycine
concentration (r =
—0.78, P < 0.0001). As reported earlier [10],
the rate at which tubular reabsorption of sodium declined in the
later stages of perfusion was slowed by glycine as compared
Control Glycine
Glycine concentration
mM 0 0.1 0.25 0.5 1 2
n (16) (5) (5) (4) (5) (7)
Perfusate flow 30' 22.9 0.5 25.7 5 23.0 0.8 23.7 0.7 22.4 6 24.7 1.4
mi/minlg 60' 25.4 0.7 29.4 6 24.8 1.4 25.1 0.8 24,6 3 29.0 1.3
wet wt of kidney 90' 27.9 I 30.7 5 25.9 1.0 26.4 1.1 26.0 6.0 31.3 1.1
Urine volume 30' 66 7 54 2 50 3 47 3 72 8 49 7
mI/minig 60' 116 15 96 2 78 2 85 6 114 12 105 9
wet wt of kidney 90' 112 13 92 2 86 5 93 10 118 9 106 8
Glomerular filtration rate 30' 0.49 0.03 0.63 0.04 0,59 0.03 0.57 0.05 0.49 0.03 0.57 0.04
mi/minlg 60' 0.28 0.02 0.33 0.02 0.33 0.03 0.37 0.03 0.39 0.04 0.47 0.04
wet wt of kidney 90' 0.23 0.02 0.25 0.01 0.26 0.02 0.32 0.07 0.35 0.04 0.41 0.04
Tubular reabsorption of sodium % 30'
60'
90'
94.46 0.55
91.03 1.23
90.28 1.44
96.39 0.39
95.40 0.55
94.32 0.99
96.23 0.60
96.27 0.72
95.31 0.88
96.59 0.48
96.05 1.24
95.18 1.62
93.96 1.52
95.3 1.21
95.3 1.22
95.72 0.77
94.19 0.97
94.23 0.88
Tubular reabsorption of glucose % 30'
60'
90'
94.09 1.13
77.16 1.86
68.83 1.57
98.58 0.31
87.15 2.49
77.31 2.21
98.98 0.21
93.26 2.01
83.89 2.35
99.03 0.20
98.76 0.32
97.7 0.42
LDH release during last 60 mm of 6.9 0.4 4.2 0.8 3.6 0.7 1.8 0.5 1.6 0.3 2.1 0.4
perfusion units
Glomerular filtration and tubular reabsorption of glucose fell significantly (P < 0.01) overtime, while perfusate flow and urine volume increased.
The rate of change over time is significantly different between groups with and without glycine for glomerular filtration (P < 0.0001), tubular
reabsorption of sodium (P < 0.0025) and glucose (P < 0.0001, 2 way ANOVA).
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with control perfusions, but urine volume and perfusion flow
rate were not affected (Table 1). Tubular reabsorption of
glucose, a function of the proximal tubule, was also improved
by glycine and correlated with glycine concentration (r = 0.4; P
<0.005 at 90 mm).
Glycine receptor agonists and antagonists
When equimolar concentrations of ACC or d-serine, which
are glycine agonists at the NMDA receptor, were substituted
for 2 mrvi glycine, mTAL necrosis was also substantially re-
duced, though not so much as with glycine (Fig. 3). As with
glycine, the most pronounced effect was noted at the deepest
(C) level of the inner stripe (P < 0.01 vs. controls). Tubular
reabsorption of glucose was significantly preserved and LDH
release was substantially lowered, but an ameliorative effect
upon the deterioration of glomerular filtration rate and frac-
tional sodium reabsorption was not statistically demonstrable
by analysis of variance (Table 2). In contrast, 1-serine and
1
V////AØi
taurine, which are agonists of the strychnine-sensitive glycine
receptor in the brain, but do not bind to the NMDA associated
glycine receptor, did not prevent tubular damage or ameliorate
renal function (Fig. 3, Table 2).
The action of glycine (0.25 mM) to prevent structural damage
to the mTAL was not inhibited by addition of the glycine
receptor antagonists indole-2-carboxylic acid, 12.5 mrvi (N 6)
or 7-Cl-kynurenic acid, 2 mM (N = 8) (Fig. 4). These agents also
did not reverse the functional protection afforded by glycine on
GFR, tubular reabsorption of glucose, and LDH release. When
given alone in 3 experiments, indole-2-carboxylic acid (12.5
mM) reduced morphological damage in the outer stripe to
approximately the same degree as 1 mivi glycine. In two
experiments, strychnine, l0— M, did not reverse the protective
effect of glycine at a concentration of 2 mM. At higher concen-
trations, strychnine produced intense vasoconstriction of the
perfused kidney, reducing the flow of perfusate.
Discussion
In isolated rat kidneys perfused with oxygenated, cell-free
medium, cellular injury develops as the result of medullary
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Fig. 1. Structural damage in medullary thick
ascending limbs (m TAL) of the inner stripe of
the outer medulla in kidneys perfused for 90
minutes with concentrations of glycine
varying from 0 (control) to 2 m. Zone A
indicates the outer third, B the mid-level, and
C the deepest portion of the inner stripe.
Symbols are: () severe damage; (E)
moderate damage.
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Fig. 2. Inulin clearance (GFR) at 60 minutes of perfusion is propor-
tional to the concentration of glycine in the recirculating perfusate (r =
0.65; P <0.000!),
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Fig. 3. Severe structural damage to deep medullary thick limbs
(mTALs) in kidneys perfused for 90 minutes with no amino acids
(control), and with 2 mw glycine, 1-amino-cyclopropane carboxy/ic acid
(ACC), d-serine, 1-serine and taurine. * P < 0.01 versus control,
ANOVA
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Table 2. EffeCt of glycine analogues on kidney function and LDH release in perfused kidneys
Control
(16)
Glycine
2 mai
(7)
Glycine
0.25 msi
(5)
ACC
2 msi
(5)
d-Serine
2 mat
(5)
1-Serine
2 m
(6)
Taurine
2 mM
(6)
Flow mi/minlg
GFR mi/minlg
Fractional reabsorption of sodium %
Fractional reabsorption of glucose %
LDH release units
25.4 0.7
0.27 0.02
91.0 1.2
77.2 1.9
6.9 0.4
29.0 1.3
0.47 0.04a
94.2 0.9
98.8 0.3
2.1 O.4
24.8 1.4
0.33 0.03
96.3 0.72
87.2 2,5a
3.6 0.7a
30.5 1.0
0.41 0.04
94.6 0.6
93,4 2.2a
4.0 0.7"
25.1 0.6
0.34 0.03
94.3 0.7
88.3 1.2k
3.5 0.6a
30.6 1.4
0.33 0.02
83.8 1,2
75.8 5.9
5.2 0.9
23.2 1.1
0,28 0.03
93.3 1.4
83.4 2.6
5.2 0.4
Values shown were obtained at 60 minutes of perfusion, with the exception of LDH release, which includes total LDH released into urine and
perfusate during the last hour of perfusion; that is from 30 to 90 minutes.
a P < 0.01 versus control
b p < 0.05 versus control
Fig. 4. Severe structural damage to deep medullary thick limbs
(mTALs) in control kidneys (N = 16) and those perfused with 0.25 mi
glycine (N = 5), 0.25 M glycine plus 12.5 miw indole-2-carboxylic acid (N
= 6), and 0.25 M glycine plus 2 m 7-chlorokynurenic acid (N = 7). The
percent severe damage in control kidneys is significantly greater from
that in all 3 groups of kidneys perfused with glycine (P < 0.01), but the
latter 3 do not differ significantly from each other.
hypoxia. Morphological signs of damage are most apparent in
the thick ascending limb of Henle's loop and are correlated with
a decline in glomerular filtration rate and a decrease in frac-
tional reabsorption of sodium [18]. The addition of glycine to
the recirculating medium prevents morphological evidence of
mTAL damage and improves kidney function [10]. While struc-
tural injury is most obvious in the medullary thick ascending
limbs of isolated perfused rat kidneys, the present experiments
provide evidence of functional damage to proximal tubular cells
as well as in the form of a reduction in the fractional reabsorp-
tion of glucose that is preventable with glycine. Fractional
glucose reabsorption was progressively depressed in control
kidneys perfused without glycine, but maintained at a high level
by the addition of glycine to the recirculating perfusate. These
changes most likely reflect damage to the straight portion of the
proximal tubule (S3), contained in the outer medulla and the
medullary rays, which are known to be susceptible to hypoxic
injury. Glycine also diminished the release of lactic dehydroge-
nase into urine and medium, an index of tubular cell injury.
In the present report we present evidence that the protective
effect of glycine upon the isolated perfused kidney is dose-
dependent, with significant morphological and functional pres-
ervation at a glycine concentration of 0.25 X i03 M. It should
be noted that this concentration of glycine is considerably
higher than the binding affinity of glycine receptors described in
the brain, which are usually in the nanomolar range [15, 17—19].
Cytoprotection was also obtained in this model with certain
glycine analogues and amino acids that bind to glycine recep-
tors present in the central nervous system. Two types of
receptors have been described. An inhibitory glycine receptor
that opens a chloride channel is blocked by strychnine; its
agonists include l-serine, taurine, d-alanine and 1-alanine. A
second glycine receptor is associated with the N-methyl-d-
aspartate (NMDA) receptor, modifying it in the direction of
excitation. This receptor is insensitive to strychnine but inhib-
ited by a number of compounds, including 7-Ci-kynurenic acid
and indole-2-carboxylic acid. Agonists to this receptor include
d-serine and 1-aminocyclopropane carboxylic acid (ACC).
In the present experiments in the isolated perfused kidney,
functional and morphological integrity was maintained by ACC
and d-serine, specific agonists of the strychnine-insensitive
glycine receptor in neural cells. On the other hand, 1-serine and
taurine, which are agonists of the strychnine-sensitive glycine
receptor, but do not bind to the strychnine-insensitive glycine
receptor, lacked this protective effect.
A cytoprotective action of ACC was also noted by Weinberg
et al in dispersed proximal tubules of rabbit kidney exposed to
anoxia [3]. In that system, l-alanine, d-alanine and beta-alanine
also provided some protection, while neither d-nor 1-serine
were effective in blunting injury. These authors suggested that
"the effects of glycine analogues appear to be determined by
strict requirements of molecular mimicry." Baines, Shaikh and
Ho found that at a concentration of 5 mrvi, glycine, 1-alanine,
d-alanine and beta-alanine all prevented functional deteriora-
tion and release of enzymes in the isolated perfused rat kidney
and that the effect of glycine was not vitiated by blocking its
intermediary metabolism with cysteamine. They suggested an
ability of these small molecules "to stabilize tertiary protein
structure and membrane structure [9]."
It is natural to speculate that the molecular configuration
responsible for the cytoprotective action of glycine and its
analogues in epithelial cells might be related to that of specific
glycine receptors already studied intensively in neural tissue.
Evidence for this, however, is mixed. The binding constant for
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glycine and related compounds in brain membranes is in the
nanomolar range, while the lowest concentration of glycine
found to protect kidney cells from anoxic injury is 2.5 x l0— M.
The marked protection of mTALs in isolated perfused kidneys
afforded by ACC and d-serine, both agonists of the strychnine-
insensitive NMDA-associated glycine receptor, suggests a spe-
cific congruence with this receptor that is supported by the
ineffectiveness of the optical isomer of d-serine (1-serine), an
agonist of the strychnine-sensitive receptor. However, other
agonists of the strychnine-sensitive receptor but not of the
NMDA receptor, that is, 1-alanine and beta-alanine, do provide
cytoprotection to renal cells [3, 9, 10, 13], though taurine, which
binds to the strychnine-sensitive receptor, does not, either in
dispersed proximal tubules [3], or, as in the present experi-
ments, in medullary thick limbs of the perfused rat kidney.
Two selective inhibitors of strychnine-insensitive glycine
receptors were tested: 2.5 mrvi 7-chioro-kynurenic acid (tested
at lOx the ambient glycine concentration) and 12.5 mM indole-
2-carboxylic acid (tested at 50x the ambient glycine concentra-
tion). Neither was effective in reversing the cytoprotection
provided by 0.25 mi glycine. In these experiments the ratio of
the concentration of putative antagonist to that of glycine
approximated that reported to be effective in preventing the
binding of glycine to brain receptors [19, 20]. We were unable to
test higher concentrations of antagonist compounds owing to
their limited solubility in the perfusing medium.
In summary, the protection against hypoxic cell injury in
isolated perfused kidneys that is provided by glycine is mim-
icked by 1-amino-cyclopropane carboxylic acid and d-serine,
both glycine analogues that are active on the strychnine-
insensitive glycine receptor in brain membranes. By contrast,
1-serine and taurine, which are inactive on this receptor, though
active agonists on the strychnine-sensitive receptor, did not
provide protection. Two glycine receptor antagonists in brain,
however, did not reverse the glycine effect. On balance, the
results of these and other studies favor a ligand-acceptor type of
interaction to account for cytoprotection, rather than one
involving the metabolism of glycine. The molecular configura-
tion of the acceptor involved in glycine's cytoprotective action
may bear some resemblance to certain glycine receptors in the
nervous system.
